Literature DB >> 2123825

Defect in the tissue cellular immune response: experimental visceral leishmaniasis in euthymic C57BL/6 ep/ep mice.

K E Squires1, M Kirsch, S C Silverstein, A Acosta, M J McElrath, H W Murray.   

Abstract

In BALB/c mice, successful defense against visceral leishmaniasis is T cell dependent, expressed by tissue granuloma formation, and probably mediated by macrophages activated by cytokines, including gamma interferon (IFN-gamma). C57BL/6 ep/ep (pale ear) mice, which reportedly exhibit impaired IFN-gamma production, were challenged with Leishmania donovani to determine the outcome of infection in a euthymic host with an apparent defect in lymphokine secretion. In BALB/c and normal C57BL/6 mice, L. donovani liver burdens peaked at 2 weeks and were largely eliminated by 4 weeks. In contrast, in pale ear mice, infection progressed until after 4 weeks and persisted at high levels at 8 weeks. The failure to resolve hepatic infections was not related to deficiencies in (i) Thy-1+, L3T4+, or Lyt-2+ T cells; (ii) IFN-gamma secretion; (iii) liver tissue Ia expression; (iv) macrophage antimicrobial capacity; or (v) antileishmanial antibody production. However, despite the anticipated influx of mononuclear cells into livers, these cells were not properly focused on the parasitized Kupffer cells, the inflammatory infiltrate receded prematurely, and mature granulomas failed to develop. These results suggest that there is a cellular immune defect at the tissue level and emphasize the critical role of granuloma formation in successful resolution of systemic intracellular infections.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2123825      PMCID: PMC313751          DOI: 10.1128/iai.58.12.3893-3898.1990

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  25 in total

1.  The granulomatous inflammatory response. A review.

Authors:  D O Adams
Journal:  Am J Pathol       Date:  1976-07       Impact factor: 4.307

2.  Monoclonal antibodies to murine gamma-interferon which differentially modulate macrophage activation and antiviral activity.

Authors:  R D Schreiber; L J Hicks; A Celada; N A Buchmeier; P W Gray
Journal:  J Immunol       Date:  1985-03       Impact factor: 5.422

3.  Human mononuclear phagocyte antiprotozoal mechanisms: oxygen-dependent vs oxygen-independent activity against intracellular Toxoplasma gondii.

Authors:  H W Murray; B Y Rubin; S M Carriero; A M Harris; E A Jaffee
Journal:  J Immunol       Date:  1985-03       Impact factor: 5.422

4.  Killing of intracellular Leishmania donovani by lymphokine-stimulated human mononuclear phagocytes. Evidence that interferon-gamma is the activating lymphokine.

Authors:  H W Murray; B Y Rubin; C D Rothermel
Journal:  J Clin Invest       Date:  1983-10       Impact factor: 14.808

5.  Human monocyte activation for cytotoxicity against intracellular Leishmania donovani amastigotes: induction of microbicidal activity by interferon-gamma.

Authors:  D L Hoover; C A Nacy; M S Meltzer
Journal:  Cell Immunol       Date:  1985-09       Impact factor: 4.868

6.  Anti-striated muscle antibody activity produced by Trypanosoma cruzi.

Authors:  A M Acosta; M Sadigursky; C A Santos-Buch
Journal:  Proc Soc Exp Biol Med       Date:  1983-03

Review 7.  The immunobiology of leishmaniasis.

Authors:  R D Pearson; D A Wheeler; L H Harrison; H D Kay
Journal:  Rev Infect Dis       Date:  1983 Sep-Oct

8.  Leishmaniasis in beige mice.

Authors:  C E Kirkpatrick; J P Farrell
Journal:  Infect Immun       Date:  1982-12       Impact factor: 3.441

9.  Activation of mouse peritoneal macrophages in vitro and in vivo by interferon-gamma.

Authors:  H W Murray; G L Spitalny; C F Nathan
Journal:  J Immunol       Date:  1985-03       Impact factor: 5.422

10.  Cure of murine leishmaniasis with anti-interleukin 4 monoclonal antibody. Evidence for a T cell-dependent, interferon gamma-independent mechanism.

Authors:  M D Sadick; F P Heinzel; B J Holaday; R T Pu; R S Dawkins; R M Locksley
Journal:  J Exp Med       Date:  1990-01-01       Impact factor: 14.307

View more
  9 in total

1.  Granzyme-mediated regulation of host defense in the liver in experimental Leishmania donovani infection.

Authors:  Henry W Murray; Marisa Mitchell-Flack; Hua Zheng; Xiaojing Ma
Journal:  Infect Immun       Date:  2014-12-01       Impact factor: 3.441

2.  Impairment of natural killer cell activity in Indian kala-azar: restoration of activity by interleukin 2 but not by alpha or gamma interferon.

Authors:  P P Manna; D Bharadwaj; S Bhattacharya; G Chakrabarti; D Basu; K K Mallik; S Bandyopadhyay
Journal:  Infect Immun       Date:  1993-08       Impact factor: 3.441

3.  Effector role of blood monocytes in experimental visceral leishmaniasis.

Authors:  J S Cervia; H Rosen; H W Murray
Journal:  Infect Immun       Date:  1993-04       Impact factor: 3.441

4.  Multiple host defense defects in failure of C57BL/6 ep/ep (pale ear) mice to resolve visceral Leishmania donovani infection.

Authors:  H W Murray; J Hariprashad; D F McDermott; M Y Stoeckle
Journal:  Infect Immun       Date:  1996-01       Impact factor: 3.441

Review 5.  Mechanisms of resistance and susceptibility to experimental visceral leishmaniosis: BALB/c mouse versus Syrian hamster model.

Authors:  Ana Nieto; Gustavo Domínguez-Bernal; José A Orden; Ricardo De La Fuente; Nadia Madrid-Elena; Javier Carrión
Journal:  Vet Res       Date:  2011-02-23       Impact factor: 3.683

Review 6.  Study of Leishmania pathogenesis in mice: experimental considerations.

Authors:  Corinne Loeuillet; Anne-Laure Bañuls; Mallorie Hide
Journal:  Parasit Vectors       Date:  2016-03-11       Impact factor: 3.876

7.  Morphophysiological changes in the splenic extracellular matrix of Leishmania infantum-naturally infected dogs is associated with alterations in lymphoid niches and the CD4+ T cell frequency in spleens.

Authors:  Aurea Virginia Andrade da Silva; Fabiano Borges Figueiredo; Rodrigo Caldas Menezes; Arthur Augusto Mendes-Junior; Luisa Helena Monteiro de Miranda; Elisa Cupolillo; Renato Porrozzi; Fernanda Nazaré Morgado
Journal:  PLoS Negl Trop Dis       Date:  2018-04-20

8.  Establishment, optimisation and quantitation of a bioluminescent murine infection model of visceral leishmaniasis for systematic vaccine screening.

Authors:  Han Boon Ong; Simon Clare; Adam Jonathan Roberts; Mary Edythe Wilson; Gavin James Wright
Journal:  Sci Rep       Date:  2020-03-13       Impact factor: 4.379

9.  Modulation of Splenic B Cell Subsets during Experimental Leishmania donovani Infection in BALB/c Mice.

Authors:  Koushik Mondal; Shantanabha Das; Khudiram Naskar; Syamal Roy
Journal:  Pathogens       Date:  2021-06-29
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.